On April 24, 2026, the FDA issued Commissioner’s National Priority Vouchers (CNPVs) to three companies developing psychedelic therapies for depression and PTSD. The move could
Recent Feature: Oprah Daily We’re incredibly honored and excited that Nushama was featured in Oprah Daily’s recent in-depth cover story, A User’s Guide to Therapeutic
Discover the groundbreaking impact of psychedelic therapy. Join Good Morning America as they discuss ketamine-assisted therapy with Nushama Wellness. Find out how ketamine-assisted therapy (KAT) is transforming the lives of those with various mental health and treatment-resistant conditions.
On April 24, 2026, the FDA issued Commissioner’s National Priority Vouchers (CNPVs) to three companies developing psychedelic therapies for depression and PTSD. The move could
Recent Feature: Oprah Daily We’re incredibly honored and excited that Nushama was featured in Oprah Daily’s recent in-depth cover story, A User’s Guide to Therapeutic
Discover the groundbreaking impact of psychedelic therapy. Join Good Morning America as they discuss ketamine-assisted therapy with Nushama Wellness. Find out how ketamine-assisted therapy (KAT) is transforming the lives of those with various mental health and treatment-resistant conditions.
